China’s DeepSeek unveils experimental version of its V3 AI model before National Day holiday


Chinese artificial intelligence start-up DeepSeek has launched an “experimental” version of its V3 foundation model ahead of the country’s National Day holiday, as the Hangzhou-based company accelerates its product releases.

On Monday, DeepSeek released V3.2-Exp and open-sourced it on developer platforms Hugging Face and Alibaba Group Holding-backed ModelScope. According to DeepSeek, this model enhanced training and inference efficiency while reducing application-programming-interface costs by more than 50 per cent compared with previous versions.

V3.2-Exp is available on DeepSeek’s website and app.

The move followed closely on the heels of DeepSeek’s previous release, DeepSeek-V3.1-Terminus, which debuted just a week earlier, and came two months after V3.1 was introduced. The original V3 model was launched in December.

The industry is paying close attention to DeepSeek’s new products after the start-up said last month that it would tailor its models for next-generation AI chips developed in China.

10:41

How Hangzhou’s ‘Six Little Dragons’ built a new Chinese tech hub

How Hangzhou’s ‘Six Little Dragons’ built a new Chinese tech hub

In January, just before the Lunar New Year, DeepSeek launched its R1 reasoning model, which generated considerable excitement at home and abroad, and prompted domestic competitors to keep employees at work during one of the country’s most important holidays of the year.
  • Related Posts

    JD.com posts first quarterly loss in nearly four years as delivery battle takes toll

    Chinese e-commerce giant JD.com reported a 2.7 billion yuan (US$392 million) loss in the fourth quarter and a halving of annual profit amid an ongoing food delivery battle it ignited…

    Continue reading
    China and Hong Kong should relax biotech listing rules, venture capitalist says

    Mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalise on renewed foreign interest in the healthcare sector, venture…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *